Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
72°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lantheus Holdings
(NQ:
LNTH
)
107.16
+4.93 (+4.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lantheus Holdings
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Assessing Lantheus Holdings: Insights From 4 Financial Analysts
February 23, 2024
Via
Benzinga
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 22, 2024
Shares of Etsy, Inc.
Via
Benzinga
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
February 22, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is NASDAQ:LNTH on the Verge of a Major Breakout as a Strong Growth Stock?
February 08, 2024
Why LANTHEUS HOLDINGS INC (NASDAQ:LNTH) Is a Promising High-Growth Stock in the Midst of Consolidation.
Via
Chartmill
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
February 22, 2024
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
NASDAQ:LNTH stands out as a growth opportunity that won't break the bank.
February 16, 2024
While growth is established for LANTHEUS HOLDINGS INC (NASDAQ:LNTH), the stock's valuation remains reasonable.
Via
Chartmill
Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging
February 13, 2024
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time
February 08, 2024
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
NASDAQ:LNTH is showing good growth, while it is not too expensive.
January 26, 2024
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
Via
Chartmill
Deep Dive Into Lantheus Holdings Stock: Analyst Perspectives (4 Ratings)
January 10, 2024
Via
Benzinga
Earnings Scheduled For February 22, 2024
February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
Via
Benzinga
Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued.
December 25, 2023
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued gem with solid fundamentals.
Via
Chartmill
NASDAQ:LNTH—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
December 14, 2023
LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a strong growth stock, setting up for a breakout.
Via
Chartmill
For those who appreciate value investing, NASDAQ:LNTH is a compelling option with its solid fundamentals.
February 05, 2024
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): good value for what you're paying.
Via
Chartmill
Lantheus Announces CEO Succession Plan
January 23, 2024
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
For those who appreciate value investing, NASDAQ:LNTH is a compelling option with its solid fundamentals.
January 15, 2024
Don't overlook LANTHEUS HOLDINGS INC (NASDAQ:LNTH)—it's a hidden gem with strong fundamentals and an attractive price tag.
Via
Chartmill
Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)
January 11, 2024
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics
January 09, 2024
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Reports Preliminary Fiscal Year 2023 Revenue
January 09, 2024
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
January 05, 2024
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced.
Via
Chartmill
Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
New Year, New Gains: The 3 Best AI Stocks to Buy in 2024
January 01, 2024
These AI stocks offer substantial upside potential compared to the overextended chip players that dominated the theme in 2023.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
December 19, 2023
Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 18, 2023
Via
Benzinga
Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today?
December 18, 2023
Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic castration-res
Via
Benzinga
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 18, 2023
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 18, 2023
Via
Benzinga
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
December 18, 2023
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced.
December 15, 2023
Despite its growth, NASDAQ:LNTH remains within the realm of affordability.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.